Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-001658
Filing Date
2007-03-15
Accepted
2007-03-15 17:16:39
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 BENTLEY PHARMACEUTICALS, INC. b64563bpe10vk.htm 10-K 1204116
2 EX-10.29 SETTLEMENT TERM SHEET AGREEMENT b64563bpexv10w29.htm EX-10.29 14397
3 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b64563bpexv21w1.htm EX-21.1 7309
4 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b64563bpexv23w1.htm EX-23.1 1950
5 EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b64563bpexv31w1.htm EX-31.1 8805
6 EX-31.2 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b64563bpexv31w2.htm EX-31.2 8646
7 EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b64563bpexv32w1.htm EX-32.1 4027
8 EX-32.2 SECTION 906 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b64563bpexv32w2.htm EX-32.2 4037
  Complete submission text file 0000950135-07-001658.txt   1254802
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10581 | Film No.: 07697296
SIC: 2834 Pharmaceutical Preparations